These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21999583)

  • 1. Evaluation of deleted in malignant brain tumors 1 (DMBT1) gene expression in bladder carcinoma cases: preliminary study.
    Dodurga Y; Avci CB; Yilmaz S; Dogan ZO; Kesen Z; Tataroglu C; Satiroglu-Tufan NL; Bushra T; Gunduz C
    Biomarkers; 2011 Nov; 16(7):610-5. PubMed ID: 21999583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
    Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
    Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
    Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
    Amsellem-Ouazana D; Bièche I; Molinié V; Elie C; Vieillefond A; Tozlu S; Botto H; Debré B; Lidereau R
    Eur Urol; 2006 Jun; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof].
    Song T; Hong BF; Gao JP; Cai W; Wang CY
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):806-7. PubMed ID: 17565859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.
    Yamanaka M; Kanda K; Li NC; Fukumori T; Oka N; Kanayama HO; Kagawa S
    J Urol; 2001 Dec; 166(6):2495-9. PubMed ID: 11696817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
    Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
    Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Wolff I; Schostak M; Tabiti K; Müller M; Miller K; Schrader M
    Cancer Lett; 2007 Jan; 245(1-2):121-6. PubMed ID: 16473461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
    Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
    Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.
    Dodurga Y; Avcı CB; Satiroglu-Tufan NL; Tataroglu C; Kesen Z; Doğan ZO; Yılmaz S; Gündüz C
    Mol Biol Rep; 2012 Apr; 39(4):4691-5. PubMed ID: 21956756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcripts of SFRP1,CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder.
    Buim ME; Soares FA; Sarkis AS; Nagai MA
    Oncology; 2005; 69(6):445-54. PubMed ID: 16410684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 gene expression study and early bladder carcinogenesis.
    Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
    Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
    Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
    Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder.
    Das K; Zhao Y; Sugiono M; Lau W; Tan PH; Cheng C
    Urol Oncol; 2007; 25(4):317-21. PubMed ID: 17628298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues].
    Ren L; Hou SK; He LF; Ye HY; Guan KP
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1104-7. PubMed ID: 15498296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.